John Schroeder

On Monday during his first day in office, President Trump signed an Executive Order (EO) freezing the pending LCD policy that would limit access to skin substitutes for chronic wound care. To be clear - this is a policy freeze pending further action.

While the top six major insurance companies have reported soaring profits—some rising by thousands of percentage points since the Medicare Advantage program was enacted, many patients enrolled in Medicare Advantage plans claim they didn’t even realize they were leaving traditional Medicare. This lack of transparency raises important questions about how these plans are marketed and the tactics used to encourage patients to switch.

Under a system previously reliant solely on hospital outpatient departments, many patients—especially the elderly in care facilities, the poor, the homebound, the rural, and the otherwise disenfranchised—never enjoyed equitable access. Today, however, more patients than ever are receiving wound care as providers are motivated to bring advanced modalities directly to them.

The national ASP publication of AmnioWrap2™ knocks down barriers that will provide healthcare professionals and their patients with the opportunity to use AmnioWrap2™, a superior wound care product for certain applications.

Caroline Fife, M.D. highlights a concerning discrepancy between the characteristics of patients with chronic wounds in real-world settings and those selected for clinical trials.